ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,463Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 229

$293K Total Retail Price of All Prescriptions

Rank: 95 out of 229

458 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 458 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 458 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 5,602 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 473 415 1 1
LISINOPRIL 399 322 2 2
SIMVASTATIN 360 291 3 3
AMLODIPINE BESYLATE 303 250 4 5
OMEPRAZOLE 291 194 5 4
ALENDRONATE SODIUM 285 267 6 14
METFORMIN HCL 205 149 7 6
LOSARTAN POTASSIUM 184 137 8 12
GABAPENTIN 180 104 9 10
HYDROCHLOROTHIAZIDE 179 139 10 9
LOVASTATIN 159 153 11 11
ATENOLOL 132 113 12 19
PRAVASTATIN SODIUM 122 101 13 25
RANITIDINE HCL 113 82 14 32
PROAIR HFA 103 52 15 38
HYDROCODONE-ACETAMINOPHEN 99 66 S3 16 7
POTASSIUM CHLORIDE 97 83 17 18
FUROSEMIDE 84 63 18 8
FLUTICASONE PROPIONATE 75 46 19 23
TRAMADOL HCL 71 42 20 26
CITALOPRAM HBR 69 53 21 21
TRAZODONE HCL 65 48 22 34
TRIAMTERENE-HCTZ 64 49 23 51
GLYBURIDE 64 52 R 23 57
ZOLPIDEM TARTRATE 63 38 25 20
ALLOPURINOL 60 42 26 27
SERTRALINE HCL 58 30 27 22
FLOVENT HFA 58 41 27 115
METOPROLOL SUCCINATE 58 47 27 16
DIOVAN 57 51 30 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 46 31 28
MIRTAZAPINE 55 51 31 52
FLUOXETINE HCL 55 13 31 41
GLIPIZIDE 53 52 34 36
TAMSULOSIN HCL 53 49 34 24
METOPROLOL TARTRATE 52 37 36 13
JANUVIA 51 46 37 59
MELOXICAM 51 35 37 45
ATORVASTATIN CALCIUM 51 35 37 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.